UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	February 12, 2021

Accession Number:
Submission Type:
CIK: 0001228627 Company Name: Ocuphire Pharma, Inc. File Number: 333-252715